TE_38955
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | HERV15 |
---|---|
TE superfamily | ERV1 |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 1.11 |
Counts of samples | TCGA_tumor:85; TCGA_normal:12; GTEx:74 |
TSS | chrY(-):12318429 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_38955.1 | - | Intergenic | Non-coding | Non-coding | chrY(-):12288038,12288058,12318035,12318430 |
teRNA_38955.2 | - | Intergenic | Non-coding | Non-coding | chrY(-):12288038,12288058,12289848,12289965,12318035,12318430 |
teRNA_38955.3 | - | Intergenic | Non-coding | Non-coding | chrY(-):12288038,12288058,12289803,12289965,12318035,12318430 |
teRNA_38955.4 | - | Intergenic | Non-coding | Non-coding | chrY(-):12288038,12288058,12303088,12303163,12318035,12318430 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.